Loading clinical trials...
Loading clinical trials...
This will be a stepped wedge randomized trial design to evaluate the implementation of cryptococcal antigen (CRAG) screening and preemptive anti-fungal therapy of HIV-infected persons entering antiret...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Minnesota
Collaborators
NCT00001352 · Cryptococcal Infection, Cryptococcal Pneumonia, and more
NCT06666322 · Hiv, Cryptococcal Meningitis
NCT05685641 · Acquired Immunodeficiency Syndrome, Histoplasmosis AIDS, and more
NCT03002012 · Cryptococcosis, Cryptococcal Infections, and more
NCT01802385 · Cryptococcal Meningitis, Fungal Meningitis
Infectious Disease Institute, Makerere University
Kampala
Kampala Capital Council Authority Clinics
Kampala
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions